Physician profile
Dan E Robinson
NPI 1013139898
$169,682.81
in general payments reported to CMS, 2019-2025
7 companies · $1,596 in 2025
The $1,596 reported for 2025 was more than what 79% of Foot & Ankle Surgery providers received nationally (typical 2025 total: $424).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $18K · 2020: $31K · 2021: $31K · 2022: $41K · 2023: $46K · 2024: $1,190 · 2025: $1,596.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Royalty Or License: $33K · Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program: $12K · Travel and Lodging: $2,984 · Food and Beverage: $332.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Royalty Or License | $33,213.16 |
| Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program | $12,249.90 |
| Travel and Lodging | $2,984.22 |
| Food and Beverage | $332.00 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Trilliant Surgical LLC. | $120,887.49 | 2019-2023 | Arsenal Sinus Support Plate |
| Acumed LLC | $29,532.34 | 2022-2025 | Osteomed, Acumed |
| Osteomed LLC | $19,152.49 | 2019-2022 | |
| Stryker Corporation | $68.46 | 2024 | Sonicanchor, Augment Injectable |
| Organogenesis INC. | $19.43 | 2019 | |
| Orthofix Medical, INC. | $11.99 | 2019 | |
| Si-Bone, INC. | $10.61 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Dan Robinson listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.